Skip to Main Content

What happens when you CRISPR people?

Few questions generated more contentious discussion in biotech in the mid-2010s, as researchers and executives debated the relative merits of preclinical studies that pointed both to the new gene-editing tool’s potential to cure numerous diseases and its potential to cause unintended genetic damage.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment